Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2.
about
Targeting histone methyltransferases and demethylases in clinical trials for cancer therapyEZH2 in Bladder Cancer, a Promising Therapeutic TargetKey nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancerDiverse involvement of EZH2 in cancer epigeneticsHMGA1-pseudogene overexpression contributes to cancer progressionNoncoding RNAs in endocrine malignancyAberrant regulation of FBW7 in cancer.Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcomaRegulation and Role of EZH2 in CancerMicroRNA Deregulation in Anaplastic Thyroid Cancer Biology.Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseasesAntitumor effects of pharmacological EZH2 inhibition on malignant peripheral nerve sheath tumor through the miR-30a and KPNB1 pathway.Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma.MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma.MiR-25 promotes hepatocellular carcinoma cell growth, migration and invasion by inhibiting RhoGDI1Altered expression of mir-222 and mir-25 influences diverse gene expression changes in transformed normal and anaplastic thyroid cells, and impacts on MEK and TRAIL protein expression.Proliferation inhibition and the underlying molecular mechanisms of microRNA-30d in renal carcinoma cells.Regulation of autophagy by miR-30d impacts sensitivity of anaplastic thyroid carcinoma to cisplatinDeregulation of microRNA expression in thyroid tumors.MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.Aggressive variants of follicular cell derived thyroid carcinoma; the so called 'real thyroid carcinomas'.Roles of enhancer of zeste homolog 2: from skeletal muscle differentiation to rhabdomyosarcoma carcinogenesis.Aggressive variants of follicular cell-derived thyroid carcinomas: a cytopathologist's perspective.MicroRNA regulation of F-box proteins and its role in cancer.The role of microRNAs in different types of thyroid carcinoma: a comprehensive analysis to find new miRNA supplementary therapies.Long noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR).BRAF-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone Receptor.Deconvoluting the complexity of microRNAs in autophagy to improve potential cancer therapy.miR-25 targets the modulator of apoptosis 1 gene in lung cancer.The miR-30 family: Versatile players in breast cancer.Circulatory miR-628-5p is downregulated in prostate cancer patients.Expression of MicroRNAs in Thyroid Carcinoma.MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.miR-30d is related to asbestos exposure and inhibits migration and invasion in NCI-H2452 cellsBANCR: a cancer-related long non-coding RNAMicroRNAs and complex diseases: from experimental results to computational models.EZH2 Overexpression as a Useful Prognostic Marker for Aggressive Behaviour in Thyroid Cancer.MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.miR-30d inhibits cell biological progression of Ewing's sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways in vitro.Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma.
P2860
Q26746038-DEF5EB59-ECFF-47A0-8828-F319F4A49D82Q28082054-65887364-5464-4DB6-8A9A-6C6C0602DB5DQ28082679-F26CA750-E582-4494-AD8A-B9830536EA04Q28084911-ED9DDA0E-AB95-42C0-9AE4-13B3A29A8BA9Q28608654-21415CDF-6EE9-4DAE-8C12-9F0B09D3812EQ33577889-718AC187-034B-4A50-A33A-C2545F117167Q33688508-011E7708-5F13-4991-A184-DAC2F0E4518EQ33779486-5C9DFD1C-4C0C-47C3-BFDE-B5FD2FC1A734Q34043370-FEA37567-D89D-4B1C-B3A2-248A8699637DQ34119098-694D4A86-2B6F-4879-A296-06D5C7C0C553Q34391443-4843FB2E-BBAD-4B45-9E98-EA9F6BB2B369Q35170116-3C76E623-65DD-4D76-A2F9-0FF2D7288471Q35689701-20811AD3-C11F-4DE2-9E58-0BF2CBB05B4CQ35943345-A74989C2-F81B-4A06-812B-AEEE9A898F56Q36546618-B16EE2BC-BF5D-412B-96D5-42CB6E016101Q37071712-0E9A6CF6-18B4-40FC-A7A4-EC0A4BE11DE1Q37575126-B1CDE27D-9A60-4CD3-BC06-77792528E1BAQ37588022-9CB14C66-D360-4F40-BBD6-11D424F1F8A7Q37640384-389AEF79-9C6B-4A25-AE41-5FCE7AB53029Q37668198-3C80071D-DA65-4062-8109-A8465E8D1A32Q38102673-23A0E333-1148-4406-A399-7A59EBA2575BQ38185265-953B3F06-033E-42EC-99A1-388205D5C2AAQ38199071-337277A3-1B69-4D5D-8DC4-26519E512804Q38577492-CB88C566-8690-481B-AB99-A99723FCE67DQ38650146-5ABFD213-1998-481B-B40C-277521A1C09DQ38830980-707AF246-6A10-41A6-8064-9E4BD8B1DED1Q38839297-E0F294CF-C9F0-4026-BD3E-8DDDE5987C47Q38839893-00EFE2DF-44C9-4AEE-9225-2F29F86B389CQ38872191-B5641430-5544-4E53-ACA8-07A2F2A4DD8BQ39202832-984ACFF3-70F6-46B2-9CDB-91068E669E19Q39260664-76A8E419-B0CF-4BC8-B37C-41E948441589Q39328260-5F90A3C4-07F7-4429-961A-E9C5ADEAA673Q41759540-E915299E-0DB3-4F28-A9BD-686C79440A51Q42022545-206AC25A-787E-4E42-A543-780B44FDB07CQ42027260-4C815888-E291-4E0C-AED3-1307DB3E6E6CQ45944835-B00A2165-02A8-43D1-A579-F8C205B997E0Q47257495-C0C20BBB-F5A2-4109-8B6A-E1D2A0CA7BD0Q49275839-D3AE0DB3-467C-40B3-9C33-C390CF3A5DC7Q52655155-FD7E3DE1-DBA1-4B80-B053-F50452215952Q54229169-C6DA274C-69D6-4547-8FD5-088F2A99BE29
P2860
Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Down-regulation of the miR-25 ...... ing the polycomb protein EZH2.
@ast
Down-regulation of the miR-25 ...... ing the polycomb protein EZH2.
@en
Down-regulation of the miR-25 ...... ing the polycomb protein EZH2.
@nl
type
label
Down-regulation of the miR-25 ...... ing the polycomb protein EZH2.
@ast
Down-regulation of the miR-25 ...... ing the polycomb protein EZH2.
@en
Down-regulation of the miR-25 ...... ing the polycomb protein EZH2.
@nl
prefLabel
Down-regulation of the miR-25 ...... ing the polycomb protein EZH2.
@ast
Down-regulation of the miR-25 ...... ing the polycomb protein EZH2.
@en
Down-regulation of the miR-25 ...... ing the polycomb protein EZH2.
@nl
P2093
P356
P1476
Down-regulation of the miR-25 ...... ting the polycomb protein EZH2
@en
P2093
Antonella Federico
Eleonora Borbone
Francesco Esposito
Giovanna Maria Pierantoni
Mara Tornincasa
Pierlorenzo Pallante
P304
P356
10.1210/JC.2011-3068
P407
P577
2012-03-07T00:00:00Z